Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlliance Pharma Regulatory News (APH)

  • This share is currently suspended. It was suspended at a price of 64.70
  • There is currently no data for APH

Notification of Major Holdings

9 Nov 2023 11:17

RNS Number : 9713S
Alliance Pharma PLC
09 November 2023

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB0031030819

Issuer Name

ALLIANCE PHARMA PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Kempen Capital Management N.V.

City of registered office (if applicable)

Amsterdam

Country of registered office (if applicable)

Netherlands

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

City of registered office (if applicable)

Country of registered office (if applicable)

5. Date on which the threshold was crossed or reached

06-Nov-2023

6. Date on which Issuer notified

08-Nov-2023

7. Total positions of person(s) subject to the notification obligation

.

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

10.189070

0.000000

10.189070

55157348

Position of previous notification (if applicable)

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB0031030819

6651289

48506059

1.212390

8.976680

Sub Total 8.A

55157348

10.189070%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

Correction of a previous notification

12. Date of Completion

08-Nov-2023

13. Place Of Completion

Amsterdam

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
HOLEAFFNEFKDFFA
Date   Source Headline
15th May 20257:00 amRNSCancellation - Alliance Pharma Plc
15th May 20257:00 amRNSCancellation of Trading
14th May 20253:30 pmRNSForm 8.3 - ALAPH LN
14th May 20253:29 pmRNSForm 8.3 - Alliance Pharma Plc
14th May 20253:25 pmRNSForm 8.3 - Alliance Pharma plc
14th May 20253:06 pmRNSForm 8.3 ALLIANCE PHARMA PLC
14th May 20251:50 pmRNSForm 8.3 - Alliance Pharma PLC
14th May 202510:35 amRNSForm 8.5 (EPT/RI) - Alliance Pharma plc
14th May 20259:46 amRNSForm 8.3 - Alliance Pharma PLC
14th May 20258:53 amGNWForm 8.5 (EPT/RI)-Alliance Pharma plc
14th May 20257:30 amRNSScheme of Arrangement Becomes Effective
14th May 20257:30 amRNSSuspension - Alliance Pharma plc
13th May 20253:30 pmRNSForm 8.3 - ALAPH LN
13th May 20253:29 pmRNSForm 8.3 - Alliance Pharma Plc
13th May 20253:25 pmRNSForm 8.3 - Alliance Pharma plc
13th May 20251:57 pmRNSForm 8.3 ALLIANCE PHARMA PLC
13th May 202510:20 amRNSForm 8.5 (EPT/RI) - Alliance Pharma plc
12th May 20253:30 pmRNSForm 8.3 - ALAPH LN
12th May 20253:00 pmRNSForm 8.3 ALLIANCE PHARMA PLC
12th May 20252:49 pmRNSCOURT SANCTION OF THE SCHEME OF ARRANGEMENT
12th May 202510:05 amRNSForm 8.5 (EPT/RI) - Alliance Pharma plc
9th May 20255:30 pmRNSAlliance Pharma
9th May 20253:30 pmRNSForm 8.3 - Alliance Pharma plc
9th May 20253:25 pmRNSForm 8.3 - Alliance Pharma plc
9th May 20252:26 pmRNSForm 8.3 ALLIANCE PHARMA PLC
9th May 202511:22 amRNSForm 8.3 - Alliance Pharma PLC 09.05.2025
9th May 202511:13 amGNWForm 8.3 - [ALLIANCE PHARMA PLC - 08 05 2025] - (CGWL)
9th May 202511:12 amRNSForm 8.5 (EPT/RI) - Alliance Pharma plc
8th May 20252:48 pmRNSForm 8.3 - ALLIANCE PHARMA PLC
8th May 202512:53 pmRNSForm 8.3 - Alliance Pharma PLC 08.05.2025
8th May 202512:02 pmRNSForm 8.3 - Alliance Pharma Plc
8th May 202510:14 amRNSForm 8.5 (EPT/RI) - Alliance Pharma plc
7th May 20253:30 pmRNSForm 8.3 - ALAPH LN
7th May 20253:07 pmRNSForm 8.3 ALLIANCE PHARMA PLC
7th May 20251:53 pmGNWForm 8.3 - [ALLIANCE PHARMA PLC - 06 05 2025] - (CGWL)
7th May 20251:37 pmRNSForm 8.3 - Alliance Pharma PLC 07.05.2025
7th May 202510:24 amRNSForm 8.5 (EPT/RI) - Alliance Pharma plc
6th May 20253:30 pmRNSForm 8.3 - ALAPH
6th May 20253:25 pmRNSForm 8.3 - Alliance Pharma plc
6th May 20253:16 pmRNSForm 8.3 - Alliance Pharma Plc
6th May 20253:15 pmRNSForm 8.3 ALLIANCE PHARMA PLC
6th May 20259:59 amRNSForm 8.5 (EPT/RI) - Alliance Pharma plc
2nd May 20253:30 pmRNSForm 8.3 - ALAPH
2nd May 20253:30 pmRNSForm 8.3 - ALAPH LN
2nd May 20252:56 pmRNSForm 8.3 ALLIANCE PHARMA PLC
2nd May 202510:11 amRNSForm 8.3 - ALLIANCE PHARMA PLC
2nd May 202510:07 amRNSForm 8.5 (EPT/RI) - Alliance Pharma plc
1st May 20253:36 pmRNSNotification of Major Holdings
1st May 20253:25 pmRNSForm 8.3 - Alliance Pharma plc
1st May 20252:02 pmRNSForm 8.3 - Alliance Pharma PLC 01.05.2025

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.